TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION

The aim of this study was to identify the optimal, characterised by minimal risk of cardiovascular events (CVE), levels of renin-angiotensin-aldosterone system (RAAS) components in patients with arterial hypertension (AH). In total, 454 patients with high-risk AH were examined (age 18-65 years; 92 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Sh. V. Akhadov, G. R. Ruzbanova, G. S. Molchanova, T. G. Talalaeva, S. N. Khoreva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2009-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1350
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839577045698347008
author Sh. V. Akhadov
G. R. Ruzbanova
G. S. Molchanova
T. G. Talalaeva
S. N. Khoreva
author_facet Sh. V. Akhadov
G. R. Ruzbanova
G. S. Molchanova
T. G. Talalaeva
S. N. Khoreva
author_sort Sh. V. Akhadov
collection DOAJ
description The aim of this study was to identify the optimal, characterised by minimal risk of cardiovascular events (CVE), levels of renin-angiotensin-aldosterone system (RAAS) components in patients with arterial hypertension (AH). In total, 454 patients with high-risk AH were examined (age 18-65 years; 92 men, 362 women). Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were assessed by radio-immune method, adrenalin and noradrenalin concentration in 24-hour urine sample – by fluorometric method, left ventricular myocardial structure and function – by echocardiography, renal function – by glomerular filtration rate (Reberg method) and 123 I-Hippuran renography. Target levels of RAAS components were defined as follows: PRA=0,22-3,0 ng/ml/h, if PAC: PRA=5-23 and PAC=0,18- 0,83 nmol/l (5-23 ng/dl). In patients with high CVE risk, the target levels of PRA=0,22-1,0 ng/ml/h and PAC: PRA=5-23 would minimize the risk of stroke, myocardial infarction, and target organ damage.
format Article
id doaj-art-a9234ae62d9f44d78553aebf7f4efb51
institution Matheson Library
issn 1560-4071
2618-7620
language Russian
publishDate 2009-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-a9234ae62d9f44d78553aebf7f4efb512025-08-04T13:00:03Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202009-06-010326321139TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSIONSh. V. Akhadov0G. R. Ruzbanova1G. S. Molchanova2T. G. Talalaeva3S. N. Khoreva4Городская поликлиника №81 САОГородская поликлиника №81 САОМосковский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, МоскваМосковский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, МоскваМосковский областной научно-исследовательский клинический институт им. М.Ф.Владимирского, МоскваThe aim of this study was to identify the optimal, characterised by minimal risk of cardiovascular events (CVE), levels of renin-angiotensin-aldosterone system (RAAS) components in patients with arterial hypertension (AH). In total, 454 patients with high-risk AH were examined (age 18-65 years; 92 men, 362 women). Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were assessed by radio-immune method, adrenalin and noradrenalin concentration in 24-hour urine sample – by fluorometric method, left ventricular myocardial structure and function – by echocardiography, renal function – by glomerular filtration rate (Reberg method) and 123 I-Hippuran renography. Target levels of RAAS components were defined as follows: PRA=0,22-3,0 ng/ml/h, if PAC: PRA=5-23 and PAC=0,18- 0,83 nmol/l (5-23 ng/dl). In patients with high CVE risk, the target levels of PRA=0,22-1,0 ng/ml/h and PAC: PRA=5-23 would minimize the risk of stroke, myocardial infarction, and target organ damage.https://russjcardiol.elpub.ru/jour/article/view/1350arterial hypertensionplasma renin activityplasma aldosterone concentrationmyocardial infarctionstroke
spellingShingle Sh. V. Akhadov
G. R. Ruzbanova
G. S. Molchanova
T. G. Talalaeva
S. N. Khoreva
TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
Российский кардиологический журнал
arterial hypertension
plasma renin activity
plasma aldosterone concentration
myocardial infarction
stroke
title TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
title_full TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
title_fullStr TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
title_full_unstemmed TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
title_short TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION
title_sort target levels of renin angiotensin aldosterone system components and their role in cardiovascular event development among patients with arterial hypertension
topic arterial hypertension
plasma renin activity
plasma aldosterone concentration
myocardial infarction
stroke
url https://russjcardiol.elpub.ru/jour/article/view/1350
work_keys_str_mv AT shvakhadov targetlevelsofreninangiotensinaldosteronesystemcomponentsandtheirroleincardiovasculareventdevelopmentamongpatientswitharterialhypertension
AT grruzbanova targetlevelsofreninangiotensinaldosteronesystemcomponentsandtheirroleincardiovasculareventdevelopmentamongpatientswitharterialhypertension
AT gsmolchanova targetlevelsofreninangiotensinaldosteronesystemcomponentsandtheirroleincardiovasculareventdevelopmentamongpatientswitharterialhypertension
AT tgtalalaeva targetlevelsofreninangiotensinaldosteronesystemcomponentsandtheirroleincardiovasculareventdevelopmentamongpatientswitharterialhypertension
AT snkhoreva targetlevelsofreninangiotensinaldosteronesystemcomponentsandtheirroleincardiovasculareventdevelopmentamongpatientswitharterialhypertension